Alexander Rudensky Appointed Immunology Program Chair

By Julie Grisham,

Wednesday, September 26, 2012

Pictured: Alexander Rudensky
Summary

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.

Alexander Y. Rudensky has been appointed the new Chair of the Immunology Program in the Sloan Kettering Institute.

Dr. Rudensky’s laboratory studies the development of white blood cells called T lymphocytes, which play a role in the immune system response to infection. This work has important implications for cancer.

Specifically, his research is focused on a subset of T lymphocytes called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors by acting on other T cells and reducing their immune response. Understanding how regulatory T cells function has many potential applications in the clinic.

The basic research in his lab is focused on determining how regulatory T cells are formed and how they function. Potential therapies that act by boosting or targeting these cells are now being explored for autoimmune diseases, such as diabetes and rheumatoid arthritis, as well as for cancer. Most types of tumors are infiltrated by regulatory T cells, which are believed to suppress the immune system’s ability to fight the tumor.

Dr. Rudensky, a native of Russia, earned his PhD degree in immunology from the Gabrichevsky Research Institute of Epidemiology and Microbiology, in Moscow. He completed a postdoctoral fellowship at the Yale School of Medicine. He joined Memorial Sloan Kettering in 2009, after more than 16 years on the faculty of the University of Washington School of Medicine. He is also a Howard Hughes Medical Institute investigator.

“I’m delighted that Sasha Rudensky has accepted our offer to become Chair of Immunology,” says Thomas J. Kelly, Director of SKI. “He is widely recognized as a brilliant scientist with exemplary leadership skills. I expect that, under his leadership, the Immunology Program will continue on the strong upward trajectory that it has already established.”

Dr. Rudensky succeeds James P. Allison, who became the Immunology Program Chair in 2004 and stepped down earlier this year.

Tags

Add new comment

We welcome your questions and comments. While we share many of them with our world-class doctors and researchers, we regret that in order to protect your privacy, we are not able to make personal medical recommendations on this forum, nor do we publish comments that contain your personal information. If you would like to consult with an MSK doctor, we encourage you to make an appointment at 800-525-2225 or request an appointment online.

Your email address is kept private and will not be shown publicly.